Filing Flows › Marimed (MRMD) › Capital expenditures
Marimed (MRMD) capital expenditures by quarter
Marimed's capital expenditures were $298K in Q2 2026 (second quarter 2026), -20% from Q1 2026. Over the last 6 quarters it ranged from $33K (Q4 2025) to $559K (Q3 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $298K | -20% | -4% |
| Q1 2026 | $373K | 11× | +40% |
| Q4 2025 | $33K | -94% | — |
| Q3 2025 | $559K | +81% | — |
| Q2 2025 | $309K | +16% | — |
| Q1 2025 | $266K | — | — |
Q2 2026 at a glance
Marimed, Q2 2026: revenue $41.9M (+6% year over year), operating margin 1.0%, net loss $3.6M, operating cash flow $2.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Marimed's capital expenditures?
Marimed's capital expenditures were $298K in Q2 2026 (second quarter 2026), -20% from Q1 2026.
How has Marimed's capital expenditures changed?
Over the last 6 quarters it ranged from $33K (Q4 2025) to $559K (Q3 2025).